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Abstract 
Despite wide applications of L-tyrosine in the market, microbial overproduction of L-
tyrosine has been a great challenge due to the complex gene regulations involved in 
its biosynthetic pathway. To this end, effects of knocking out tyrR on the L-tyrosine 
production were further explored during the strain development. Also, blocking 
cellular uptake of L-tyrosine by knocking out tyrosine transporters was examined with 
respect to L-tyrosine production. Using feedback resistant aroG and tyrA genes 
(aroGfbr and tyrAfbr hereafter) as initial overexpression targets, which encode 3-deoxy-
7-phosphoheptulonate synthase and chorismate mutase/prephenate dehydrogenase, 
respectively, various combinations of genes were subsequently overexpressed in the 
Escherichia coli wild-type and tyrR knockout strain, and their effects on the L-
tyrosine production were examined. Co-overexpression of aroGfbr, aroL and tyrC, a 
gene from Zymomonas mobilis functionally similar to tyrAfbr, but insensitive to L-
tyrosine, led to the greatest L-tyrosine production regardless of the strains and 
plasmid constructs examined in this study. The strain BTY2.13 overexpressing the 
abovementioned three genes together with the removal of the L-tyrosine-specific 
transporter (tyrP) produced 43.14 g/L of L-tyrosine by fed-batch fermentation using 
the exponential feeding followed by DO-stat feeding method. This outcome suggested 
that the tyrR gene knockout was not mandatory for the L-tyrosine overproduction, but 
the production performance of strains having tyrR appeared to be highly affected by 
vector systems and feeding methods. With an optimal vector system and a feeding 
method, tyrP knockout appeared to be more effective in enhancing the L-tyrosine than 
tyrR knockout. 
Graphical Abstract 
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Escherichia coli overexpressing aroG
fbr
, aroL and tyrC with its L-tyrosine-specific 
transporter (tyrP) removed (strain name BTY2.13) produced up to 43.1 g/L of L-
tyrosine from its fed-batch fermentation using the exponential-to-DO-stat feeding 
method. The tyrC is a gene from Zymomonas mobilis functionally similar to tyrA
fbr
, 
but insensitive to L-tyrosine. 
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1 | INTRODUCTION 
Aromatic compounds, such as those of aromatic amino acids, petrochemical aromatics 
and even aromatic polymers, are of great industrial importance materials (Luo and 
Lee 2017; Yang et al. 2018). Among them, L-tyrosine has long been considered as an 
attractive metabolite to produce due to its wide applications in pharmaceutical and 
chemical industries. L-Tyrosine is an important precursor of various secondary 
metabolites/natural products including benzylisoquinoline alkaloids, flavonoids and 
stilbenoids (Fischer et al. 2015; Katsuyama et al. 2007; Lim et al. 2011; Park et al. 
2018; Zhao et al. 2015), the Parkinson’s disease drug 3, 4-dihydroxy-L-phenylalanine 
(L-DOPA), and melanin (Chavez-Bejar et al. 2012; Lutke-Eversloh et al. 2007; Pittard 
et al. 2005). Despite a large number of preceding studies on L-tyrosine biosynthetic 
pathway, microbial overproduction of L-tyrosine still remains challenging due to a 
relatively large number of reactions required for its biosynthesis (nine enzymatic 
conversions starting with 3-deoxy-D-arabino-heptulosonate 7-phosphate as a substrate) 
and complex regulations involved both at transcription and metabolite levels (Figure 1) 
(Dell and Frost 1993; Ely and Pittard 1979; Rodriguez et al. 2014; Whipp and Pittard 
1977). Therefore, various metabolic engineering approaches (Lee et al. 2012; Lee and 
Kim 2015; Na et al. 2013; Yoo et al. 2013) have been employed to develop microbial 
strains for the enhanced production of L-tyrosine. 
 Previous efforts to overproduce L-tyrosine have mostly focused on 
deregulating transcriptional inhibition by deleting a transcriptional dual regulator 
(tyrR) and eliminating the feedback inhibition on two key enzymes, 3-deoxy-7-
phosphoheptulonate synthase (aroGfbr, D146N) and the dual-functional chorismate 
mutase/prephenate dehydrogenase (tyrAfbr, M53I/A354V) where the superscript ‘fbr’ 
refers to feedback resistant derivative; the former catalyzes the first committed step in 
the shikimate pathway (Kikuchi et al. 1997), and the latter catalyzes the first two steps 
towards L-tyrosine biosynthesis from chorismate (Figure 1) (Lutke-Eversloh and 
Stephanopoulos 2005). Lütke-Eversloh and Stephanopoulos generated a tyrosine-
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producing strain by overexpressing aroGfbr, tyrAfbr, ppsA and tktA in a tyrR deleted 
strain (Lutke-Eversloh and Stephanopoulos 2007). In another approach involving 
combinatorial overexpressions, yidB and aroK encoding quinate/shikimate 
dehydrogenase and shikimate kinase I, respectively, were also suggested as 
overexpression targets together with individual genes in the L-tyrosine biosynthetic 
pathway, which resulted in < 1.0 g/L of L-tyrosine titers from flask cultivations 
(Lutke-Eversloh and Stephanopoulos 2008). Instead of identifying and resolving 
bottlenecks one at a time, Juminaga et al. amplified the entire biosynthetic pathway of 
L-tyrosine in the wild-type Escherichia coli strain MG1655, and eliminated the 
bottlenecks by modifying plasmid copy numbers, promoter strength and gene 
arrangement as well as by increasing protein expression; the final strain produced > 2 
g/L L-tyrosine from the flask cultivation (Juminaga et al. 2012). Global transcriptional 
machinery engineering was also employed to further improve the L-tyrosine 
production. A high-throughput screening of mutagenesis libraries identified mutant 
strains exhibiting up to a 114% increase in L-tyrosine titer compared to the pheA- and 
tyrR-deleted parental strain overexpressing aroGfbr and tyrAfbr, and the final strain 
produced 13.8 g/L of L-tyrosine from its fed-batch fermentation (Santos et al. 2012). 
 Despite previous intense efforts, there still exists a room for the microbial 
strains’ L-tyrosine production performance to be further improved. In particular, it is 
not clear yet whether tyrR knockout should always be conducted in substantially 
improving the L-tyrosine production. Also, blocking cellular uptake of L-tyrosine by 
knocking out tyrosine transporters was examined, for the first time to the best of our 
knowledge, with respect to the L-tyrosine production. To this end, we conducted 
metabolic engineering of E. coli strain to overproduce L-tyrosine by overexpressing 
key genes in the L-tyrosine biosynthetic pathway individually and in combinations in 
the wild-type and tyrR knockout strains. As a result, aroGfbr, aroL and tyrC, a gene 
from Zymomonas mobilis functionally similar to tyrAfbr, appeared to be the best 
combination for the overexpression, which led to the greatest L-tyrosine production; 
the three genes are responsible for the beginning, middle and near-end stage of the L-
tyrosine biosynthetic pathway (Figure 1). The strain overexpressing three genes with 
its L-tyrosine-specific transporter (tyrP) knocked out produced 43.14 g/L of L-
tyrosine from its fed-batch fermentation using the exponential-to-DO-stat method. 
While the tyrR gene knockout was not mandatory for the L-tyrosine overproduction, 
the production performance of strains having tyrR appeared to be highly affected by 
vector systems and feeding methods. With an optimal vector system and a feeding 
method, tyrP knockout appeared to be more effective in enhancing the L-tyrosine than 
tyrR knockout. 
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2 | MATERIALS AND METHODS 
2.1 | Plasmid and strain construction 
All genes used in this study were amplified from the genomic DNA of E. coli W3110 
unless noted otherwise. The tyrC gene was amplified from the genomic DNA from Z. 
mobilis subsp. mobilis (KCTC1534). The feedback-inhibition resistant mutants, 
aroGfbr (D146N) and tyrAfbr (M53I, A354V) were PCR amplified from the plasmids 
reported previously (Na et al. 2013; Yoo et al. 2013). For the general cloning purpose, 
E. coli XL1-Blue (Agilent Technology, Santa Clara, CA) was used and DNA 
manipulations were performed according to the standard procedures (Sambrook and 
Russell 2001). To combine two expression cassettes of aroGfbr-aroL and tyrAfbr or 
tyrC, unique nucleotide sequence-guided assembly was used (Torella et al. 2014a; 
Torella et al. 2014b). In brief, vectors containing two 40 bp-long specific unique 
sequences (UNS1 and UNS2, and UNS2 and UNS3) and one common unique 
sequence (UNSx) were generated (Table S1). Two internal restriction enzyme sites 
between the unique sequences were assembled using Gibson assembly method 
(Gibson et al. 2010), amplified using PCR and inserted into pTac15K plasmid 
digested with EcoRI and PstI producing pBK1 and pBK2. In the first step of 
assembling the expression cassettes of gene A and B, gene A and B were cloned into 
pTac15K or pTrc99A plasmids. Next, the entire expression cassette was amplified 
using PCR and inserted into pBK1 and pBK2 at the internal restriction enzyme sites 
between UNS1 and UNS2 (EcoRV), and between UNS2 and UNS3 (SnaBI) using 
Gibson assembly method (Gibson et al. 2009). Lastly, the two expression cassettes 
were PCR-amplified with the flanking unique sequences (UNS-cassette A-UNS2 and 
UNS2-cassette B-UNSx) and assembled with pBK1 digested EcoRV and SnaBI using 
Gibson assembly method (Gibson et al. 2009). Gene deletions were performed using 
one-step PCR-based methods as described previously (Datsenko and Wanner 2000). 
PCR was performed with the C1000 Thermal Cycler (Bio-Rad, Hercules, CA, USA) 
and all oligonucleotides used in this study were purchased from Macrogen (Seoul, 
Korea). The nucleotide sequences of UNS1, UNS2, UNS3 and UNSx are listed in 
Table S1 and all the primer sequences used in this study in Table S2. All bacterial 
strains and plasmids used in this study are summarized in Table 1. 
2.2 | Flask cultivations 
For all seed cultures, frozen cell stocks were inoculated into Luria Bertani (LB) broth 
and grown overnight at 37 °C and 200 rpm with appropriate antibiotics. The cells 
(500 µl) were then transferred to a baffled flask containing 50 ml of “MR/2 (v1.0)” 
medium (Table 2) supplemented with 3 g/L yeast extract and grown at 37 °C and 200 
rpm. IPTG (final 1 mM) was added when the OD600 reached the range of 0.6-1.0. The 
culture lasted until no further growth was confirmed (24-48 hr). ‘MR/2 (v1.0)’ 
medium consisted of 6.67 g of KH2PO4, 4 g of (NH4)2HPO4, 0.8 g of citric acid, 5 mL 
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of trace metal solution (per liter) and was further supplemented with 15 g of 
(NH4)2SO4, 20 g of glucose (anhydrous), 0.8 g of MgSO47H2O, and 3 g of yeast 
extract (per liter). The pH of the medium was adjusted to 6.8 using NaOH. Trace 
metal solution contained (per liter) 10 g of FeSO47H2O, 1.35 g of CaCl2, 2.2 g of 
ZnSO47H2O, 0.58 g of MnSO44H2O, 1.0 g of CuSO45H2O, 0.1 g of 
(NH4)6Mo7O244H2O, 0.2 g of Na2B4O710H2O and 10 ml of 35 wt% HCl. When 
necessary, 50 µg/mL of ampicillin and 25 µg/mL of kanamycin were added to the 
medium. All flask cultivations were performed at least in duplicates and error bars 
represent standard deviations. 
2.3 | Fed-batch fermentation 
For the fed-batch fermentations, frozen cell stocks were inoculated into Terrific Broth 
(TB) media, but with 10 g/L glucose added in place of glycerol, and grown for 2-6 hr 
at 37 °C and 200 rpm. These cells (0.5-2 mL) were then transferred to a baffled flask 
containing 50 mL of the fermentation media supplemented with 30 g/L glucose, and 
25 mM 3-(N-morpholino)propanesulfonic acid (MOPS; Sigma Chemical Co., St. 
Louis, MO., USA). The flasks were incubated at 37°C and 200 rpm until OD600nm 
reached 3-10 and used to inoculate a 5 L bioreactor (Bioflo 3000, New Brunswick, 
Edison, NJ, USA and CNS Biologics, Daejeon, South Korea) containing 1.6 L of the 
fermentation media supplemented with 30 g/L of glucose. The initial OD600nm within 
the bioreactor was approximately 0.04-0.2. During the fed-batch fermentation, pH, 
temperature and total airflow were kept at 6.95, 37 °C and 2.0 L/min, respectively. pH 
was maintained by adding 30% (wt%) NH4OH and the level of dissolved oxygen (DO) 
was maintained at 40% by automatic cascade control varying the agitation speed from 
500 to 1000 rpm and additional supply of pure oxygen as needed. Oxygen 
supplementation was maximally allowed up to 20% (v/v). Induction was initiated 
when the OD600 of the culture reached 75 ± 10 by addition of 1M IPTG to final 
concentration of 1 mM (based on initial tank volume). Foam formation was 
suppressed by the addition of ANTIFOAM 204 (Sigma Chemical Co., St. Louis, MO., 
USA). 
 In this study, two different feeding methods were examined for the final L-
tyrosine overproducing strain, namely ‘exponential-to-DO-stat feeding method’ and 
‘DO-stat feeding method’ along with different media for each method (Table 2). A 
medium with greater concentrations of nutrients was used for the DO-stat feeding 
method in order to support cells that are growing at the maximal rate as is the 
characteristic of culture grown when using the DO-stat feeding method; in contrast to 
the exponential or exponential-to-DO-stat feeding method, DO-stat feeding method 
feeds nutrients without controlling the cell growth rate (Lee 1996), and therefore, the 
cell culture often achieves the maximal growth rate for longer periods. The same trace 
metal solution defined above for the flask cultivations was used in both fed-batch 
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fermentations. During the fed-batch fermentation experiments, kanamycin (100 
μg/mL) was added to the media of both seed and main fermentation cultures. 
Exponential-to-DO-stat feeding method starts with an exponentially increasing feed, 
which transitions to the DO-stat feeding method at either O2 limitation or glucose 
accumulated to over 2 g/L, whichever occurred first. An initial feeding rate for the 
exponential feeding method was selected as such that it would closely match the 
glucose consumption rate at the end of a batch phase, and the feeding rate was 
increased with an exponent of 0.25 hr-1. Fed-batch stage of the fermentation was 
initiated once initial batch glucose was exhausted, as signaled by a sharp increase in 
DO typically observed 5-8 hrs after inoculation. For the DO-stat feeding method, 
feeding solution was added with approximately 4 g/L of glucose per feeding pulse 
whenever the DO was greater than 48%. Fed-batch fermentations were considered 
complete if 2 L of the feeding solution was completely consumed, or glucose 
consumption was no longer apparent. 
2.4 | Analytical procedure 
Culture samples were diluted at a ratio of 1:1 with 1.0 N HCl or 0.5 M H3PO4 and 
kept at 37 °C and 200 rpm for an hour to ensure complete dissolution of L-tyrosine 
and L-phenylalanine. The mixture was further diluted to within the calibration 
standards range with 0.1 N HCl or 0.05 M H3PO4, vortexed, and centrifuged at 13,200 
rpm for 10 min. The supernatant was collected and filtered for analysis using high-
performance liquid chromatography (HPLC; Agilent, 1100 series, Agilent 
Technologies, CA, USA). Samples were eluted with a linear gradient of 0.1% of 
trifluoroacetic acid (TFA) and acetonitrile (ACN). The mixture of 95% aqueous TFA 
solution and 5% ACN was eluted for the first 3 min and ACN concentration was 
linearly increased to 70% from 3 to 10 min. Concentrations of L-tyrosine, L-
phenylalanine and L-tryptophan were analyzed using HPCL equipped with a UV-vis 
detector set at 220 nm and an Agilent Eclipse plus C18 column. The concentration of 
glucose in the broth supernatant was measured using glucose analyzer (YSI 2700, YSI 
Life Science, Ohio, USA) after being centrifuged at 13,200 rpm for 10 min. The 
concentrations of organic acids were determined using HPLC (ProStar 210; Varian, 
Palo Alto, CA) equipped with a refractive index (Shodex RI-71, Tokyo, Japan) 
detector. A MetaCarb 87H column (300 by 7.8 mm; Varian) was eluted isocratically 
with 0.01 N H2SO4 at 60°C at a flow rate of 0.5 ml/min. 
3 | RESULTS AND DISCUSSION 
3.1 | Single overexpression of aroGfbr and tyrAfbr regulated by TyrR 
The aroGfbr and tyrAfbr genes were first individually overexpressed in order to 
examine their individual effects on the L-tyrosine production using both E. coli wild-
type and tyrR knockout strains (Figure 1). These three genes, aroGfbr, tyrAfbr and tyrR, 
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have been known to be effective manipulation targets for the enhanced production of 
L-tyrosine as they are all involved in the complete regulation of L-tyrosine 
biosynthesis (Lutke-Eversloh and Stephanopoulos 2007). For this, two different 
plasmids, pTac15K and pTrc99A, were considered to examine the effects of using 
different promoters (i.e., tac versus trc promoters, respectively) and copy numbers 
(10-12 versus 15-20 copies, respectively) when individually overexpressing aroGfbr 
and tyrAfbr (Table 1) (Sorensen and Mortensen 2005). Subsequently, the two plasmid 
constructs overexpressing aroGfbr or tyrAfbr were introduced to the wild-type E. coli 
BL21(DE3) (designated as BTY0), leading to the strains BTY0.1 (pTac15K with 
aroGfbr), BTY0.2 (pTrc99A with aroGfbr), BTY0.3 (pTac15K with tyrAfbr) and 
BTY0.4 (pTrc99A with tyrAfbr). The same plasmid constructs overexpressing aroGfbr 
or tyrAfbr were also introduced to a tyrR knockout strain (designated as BTY1), 
leading to the construction of E. coli mutant strains BTY1.1, BTY1.2, BTY1.3 and 
BTY1.4 (Table 1). 
 These eight different strains were subjected to flask cultivations, and the tyrR 
knockout mutants overexpressing aroGfbr using pTac15K or pTrc99A (i.e., BTY1.1 
and BTY1.2) produced the greatest (1,083.6 mg/L) and second best titer (806.0 mg/L) 
of L-tyrosine, respectively (Figure 2). L-tyrosine production titers from the flask 
cultivations of the BTY1.1 and BTY1.2 were greater than those from BTY0.1 and 
BTY0.2 by more than 7- and 5-fold, respectively. Meanwhile, overexpression of 
tyrAfbr was effective only in the BTY1 strains as L-tyrosine was not observed from the 
BTY0.3 and BTY0.4 strains (data not shown). It was presumed that overexpression of 
tyrAfbr was not strong enough to pull the fluxes from central carbon metabolism (i.e., 
glycolysis and pentose phosphate pathway) towards the L-tyrosine biosynthesis, 
especially in the presence of tyrR. In contrast, overexpression of aroGfbr was observed 
to be much more effective than overexpression of tyrAfbr for the L-tyrosine production 
regardless of the plasmid type. Meanwhile, a substantial amount of L-phenylalanine 
was secreted as a byproduct from the BTY1.1 and BTY1.2 (Figure 2), which suggests 
suboptimal metabolic flux distributions in these two strains. 
3.2 | Co-overexpression of two genes: tyrAfbr, aroL or aroK in addition to aroGfbr 
Upon investigation of the individual overexpression of aroGfbr and tyrAfbr, co-
overexpression of the two genes was also investigated to identify potential genetic 
interactions that could be beneficial for the L-tyrosine biosynthesis. Co-
overexpression of both aroGfbr and tyrAfbr was also previously conducted for 
developing L-tyrosine-overproducing strains (Lutke-Eversloh and Stephanopoulos 
2007). Co-overexpression of both aroGfbr and tyrAfbr genes in the E. coli wild-type 
(designated as BTY0.5) led to the production of 488.4 mg/L of L-tyrosine with a 
substantially low titer of L-phenylalanine (Figure 3). Both aroGfbr and tyrAfbr genes 
were also co-overexpressed in the tyrR deletion strain (designated as BTY1.5); the 
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resulting strain produced 552.6 mg/L of L-tyrosine, which was greater than BTY0.5, 
but less than the best-producing strain BTY1.1. 
 As BTY1.1 overexpressing only aroGfbr still showed the best L-tyrosine 
production performance among all the strains developed so far, additional gene 
overexpression targets were further examined, which may show synergistic effects 
with aroGfbr. To this end, two genes aroK and aroL encoding shikimate kinase I and II, 
respectively, were selected as additional overexpression targets, which contribute to 
reactions in the middle stage of the L-tyrosine biosynthetic pathway before 
chorismate mutase/prephenate dehydrogenase (tyrA). Overexpression of aroK (Lutke-
Eversloh and Stephanopoulos 2008) or aroL (Juminaga et al. 2012) genes was 
previously reported to have positive impacts on the aromatic amino acid biosynthesis. 
Indeed, co-overexpression of aroL with aroGfbr in both wild-type and tyrR knockout 
strains, resulting in the strains BTY0.6 and BTY1.6, outperformed BTY0.5 and 
BTY1.5, respectively with respect to the L-tyrosine production, but the positive effect 
was more drastic with the BTY1.6 strain (Figure 3). This observation suggests that the 
conversion of shikimate to shikimate phosphate catalyzed by AroL could be a critical 
rate-limiting step regulated by TyrR in addition to TyrA in the L-tyrosine biosynthetic 
pathway. However, BTY1.6’s production performance was still not as good as the 
BTY1.1 strain expressing only the aroGfbr gene. Interestingly, co-overexpression of 
aroK and aroGfbr genes in the wild-type and tyrR knockout strains (BTY0.7 and 
BTY1.7, respectively) was less effective than the co-overexpression of aroL and 
aroGfbr (Figure 3). This observation was expected to a certain extent because AroK 
was not presumed to play a major role under normal growth conditions; KM value of 
AroK (> 20 mM) is hundred-fold higher than that of AroL (DeFeyter and Pittard 1986; 
Ely and Pittard 1979). Nonetheless, although AroL is a dominant isozyme in the wild-
type E. coli (Ely and Pittard 1979; Lobner-Olesen and Marinus 1992), relative 
contribution of aroL and aroK to the L-tyrosine biosynthesis cannot be generalized 
because it appeared to be strain-dependent. For example, in the E. coli K-12 strain 
harboring aroGfbr and tyrAfbr without tyrR, aroK was more effective than aroL (Lutke-
Eversloh and Stephanopoulos 2008). In contrast, the L-tyrosine production was 
improved by replacing aroK with aroL in a strain overexpressing all the genes 
involved in L-tyrosine biosynthetic pathway (Juminaga et al. 2012). 
Additionally, overexpression of 3-dehydroquinate synthase (aroB) and shikimate 
dehydrogenase (aroE), both located upstream of AroK and AroL in the L-tyrosine 
biosynthetic pathway, was previously reported to increase metabolic fluxes toward 
shikimate (Juminaga et al. 2012). To test the effects of overexpressing these enzymes 
in combination with aroGfbr, codon-optimized aroB (aroBopt) and aroE genes were 
individually overexpressed together with aroGfbr and tested for L-tyrosine production. 
The wild-type and the tyrR knockout strains overexpressing aroGfbr and aroBopt, 
BTY0.8 and BTY1.8, respectively, produced greater titers of L-tyrosine than those 
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overexpressing aroGfbr and aroE, BTY0.9 and BTY1.9 (Figure 3). However, none of 
these overexpression combinations reached the L-tyrosine titers of BTY1.1 and 
BTY1.6.  
3.3 | Co-overexpression of three genes: tyrAfbr or tyrC in addition to aroGfbr and aroL 
This time, aroGfbr, aroL and tyrAfbr were overexpressed together, which could be 
considered as amplifying the beginning, middle and near-end stage of the L-tyrosine 
biosynthetic pathway, respectively. Co-overexpression of the three genes in the wild-
type strain (designated as BTY0.10) and in the tyrR knockout strain (designated as 
BTY1.10) resulted in the production of 760.6 and 942.6 mg/L of L-tyrosine, 
respectively, with a negligible L-phenylalanine production (Figure 4a). 
 The BTY1.10 strain’s L-tyrosine titer was somewhat promising, in 
comparison with BTY1.1 and BTY1.6, which motivated further optimization of this 
co-overexpression combination. Here, because the co-overexpression of aroGfbr and 
tyrAfbr did not result in the impressive L-tyrosine titer (Figure 3), the tyrC gene was 
considered in place of tyrAfbr, which encodes cyclohexadienyl dehydrogenase in Z. 
mobilis that functions as chorismate mutase/prephenate dehydratase, similar to tyrA, 
but in an L-tyrosine insensitive manner (Chavez-Bejar et al. 2008; Zhao et al. 1993). 
Indeed, co-overexpression of aroGfbr, aroL and tyrC in the wild-type (BTY0.11) and 
tyrR deletion strains (BTY1.11) led to the production of 923 and 1,235 mg/L of L-
tyrosine, which were values 21% and 31% higher than those from the tyrAfbr 
counterparts BTY0.10 and BTY0.11, respectively (Figure 4a). 
 Also, in order to optimize the expression levels of aroGfbr-aroL and tyrAfbr (or 
tyrC), which were under the pTac15K and pTrc99A, respectively, both expression 
cassettes of aroGfbr-aroL and tyrAfbr (or tyrC) were assembled into pBK1, yielding 
pTY12 (aroGfbr-aroL and tyrAfbr) and pTY13 (aroGfbr-aroL and tyrC). This strategy 
was coined to more efficiently implement gene manipulations through an one-vector 
system, and to minimize metabolic burden by having a lower number of plasmids 
inside a cell (Jones et al. 2000). The two plasmids pTY12 and pTY13 have tyrAfbr and 
tyrC genes, respectively, both under the same trc transcriptional promoter as the pTY4 
(tyrAfbr on pTrc99A) and pTY9 (tyrC on pTrc99A), but have a lower copy number 
due to the p15A origin in the pBK1 (Table 1). The wild-type strains harboring pTY12 
and pTY13, designated as BTY0.12 and BTY0.13, produced 1,808 and 2,004 mg/L of 
L-tyrosine, respectively, which were by far the greatest L-tyrosine titers achieved in 
this study (Figure 4b). Interestingly, the tyrR knockout strains harboring pTY12 and 
pTY13, designated as BTY1.12 and BTY1.13, produced 1,239 and 1,896 mg/L of L-
tyrosine, respectively, which were less than the BTY0.12 and BTY0.13 (Figure 4b). 
These results suggest that a high level of L-tyrosine production can be achieved even 
without the tyrR knockout by harboring pTY12 or pTY13. Although further studies 
are needed to explain the working mechanism behind this observation, co-
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overexpression of aroGfbr-aroL and tyrAfbr (or tyrC) using an one-vector system 
seemed to be more effective in amplifying the fluxes through L-tyrosine biosynthetic 
pathway than knocking out the tyrR gene. In this case, expression level of tyrB, a final 
gene committed to the biosynthesis of L-tyrosine (Figure 1), was expected to be high 
enough to support the high L-tyrosine production titer despite the presence of tyrR as 
in the case of a previous study by Juminaga et al. (2012). Furthermore, it became 
apparent that tyrC was more beneficial for the L-tyrosine production than tyrAfbr 
regardless of the production hosts (i.e., wild-type versus tyrR knockout mutant) and 
plasmid constructs (two-vector system versus one-vector system) examined. 
3.4 | Deletion of tyrosine-specific and general aromatic amino acid transporters 
Finally, genes encoding a L-tyrosine-specific H+-symporter, tyrP (Andrews et al. 1991; 
Pittard et al. 2005), and a general aromatic amino acid H+-symporter, aroP (Brown 
1970; Cosgriff and Pittard 1997), were selected for knockout studies so as to further 
optimize the L-tyrosine production by minimizing the uptake of L-tyrosine by the cell. 
To the best of our knowledge, engineering of tyrosine-specific or general aromatic 
amino acid transporters has not been attempted in E. coli for the L-tyrosine 
overproduction. To this end, single (∆tyrP and ∆aroP) and double genes (∆tyrP∆aroP) 
were knocked out in the wild-type strain, which were designated as BTY2 (∆tyrP), 
BTY3 (∆aroP), and BTY4 (∆tyrP∆aroP), respectively. This same set of genes were 
also knocked out in the tyrR knockout mutant, resulting in the BTY5 (∆tyrR∆tyrP), 
BTY6 (∆tyrR∆aroP), and BTY7 (∆tyrR∆tyrP∆aroP), respectively. All these strains 
were transformed with pTY13, the plasmid construct that yielded the best L-tyrosine 
production in the previous set of experiments (Figure 4b). As result, a series of mutant 
strains were generated: BTY2.13, BTY3.13, BTY4.13, BTY5.13, BTY6.13 and 
BTY7.13 (Table 1). For the control, the wild-type strain BTY0 and the tyrR knockout 
mutant BTY1 were also transformed with the same plasmid pTY13, resulting in the 
BTY0.13 and BTY1.13, respectively. Flask cultivation of all these strains showed that 
BTY5.13 produced by far the greatest titer of L-tyrosine in this study, 2,579 mg/L, 
followed by 2,567 mg/L from BTY2.13, 2,483 mg/L from BTY7.13, and 2,004 mg/L 
from BTY0.13 (Figure 5). Because tyrP was all removed in the best three strains 
BTY5.13, BTY2.13 and BTY7.13, its knockout could be considered to be more 
effective in improving the L-tyrosine production than tyrR knockout in the strain 
having aroGfbr-aroL and tyrC overexpressed using the one-vector system. 
3.5 | Fed-batch fermentations 
Based on the L-tyrosine titers from the flask cultivations (Figure 5), BTY0.13, 
BTY2.13, BTY5.13, and BTY7.13 were selected for fed-batch fermentations using a 
5 L bioreactor in order to examine their maximal production titers of L-tyrosine. Two 
different feeding methods were applied to these strains, namely ‘exponential-to-DO-
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stat feeding method’ (exponential feeding followed by DO-stat feeding) and ‘DO-stat 
feeding method’; this implementation was to consider that microbial strains may show 
different production performances, depending on the feeding strategies (Table 2; and 
Materials and methods). With the exponential-to-DO-stat feeding method, BTY2.13 
showed the best L-tyrosine production with a titer of 43.14 g/L and a final yield of 
0.107 g/g glucose; this is a highly competitive L-tyrosine production titer which can 
further be improved through subsequent bioprocess engineering (Patnaik et al. 2008). 
In contrast, using the DO-stat feeding method, BTY7.13 showed the best L-tyrosine 
production with a titer of 28.73 g/L and a final yield of 0.069 g/g glucose. It should be 
noted that while the two strains BTY5.13 and BTY7.13 showed similar L-tyrosine 
production titers using the two different feeding methods, BTY2.13 showed markedly 
different L-tyrosine titers: 43.14 g/L from the exponential-to-DO-stat feeding method 
versus 8.6 g/L from the DO-stat feeding method (Table 3). BTY0.13 also showed a 
rather notable difference in the final L-tyrosine titers: 8.35 g/L from the exponential-
to-DO-stat feeding method versus 11.55 g/L from the DO-stat feeding method (Table 
3). 
Such varied observations for the BTY0.13 and BTY2.13 strains, depending on the 
feeding methods, could be attributed to the roles played by tyrR in response to 
different culture environments triggered by the two different feeding methods. In this 
context, absence of tyrR in BTY5.13 and BTY7.13 might have contributed to their 
stable L-tyrosine production performances regardless of the feeding methods. Also, as 
expected, BTY0.13 and BTY2.13, both having the tyrR gene, produced a greater 
amount of acetic acid as a byproduct when using the DO-stat feeding method than 
when using the exponential-to-DO-stat feeding (Table 3); the DO-stat feeding method 
feeds nutrients without controlling the cell’s growth rate (Lee 1996), and therefore the 
cells were likely to enter the overflow metabolism, producing acetic acid as a 
byproduct (Szenk et al. 2017). However, BTY5.13 and BTY7.13, both without tyrR, 
produced less amount of acetic acid when using the DO-stat feeding method (Table 3), 
which suggests a different regulatory network established upon the tyrR knockout. 
Presence or absence of tyrR in the production strains could also be a potential reason 
for very different L-tyrosine titers from BTY2.13 versus BTY5.13 and BTY7.13 from 
their fed-batch fermentation profiles (Table 3), whereas the three strains all showed 
similar L-tyrosine production titers from the flask cultivations (Figure 5). Taken 
together, the L-tyrosine overproducing strains having tyrR such as BTY0.13 and 
BTY2.13 should be thoroughly investigated with various cultivation modes and/or 
feeding methods because the effects of tyrR on the L-tyrosine production titer can be 
drastic, depending on the culture environment. A challenge here is to identify an 
optimal cultivation mode and/or feeding method (e.g., the exponential-to-DO-stat 
feeding method) that allows the L-tyrosine overproducing strain to maximally 
produce L-tyrosine even without necessitating the knockout of tyrR gene. 
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4 | CONCLUSIONS 
In this study, we investigated the effects of overexpressing and/or knocking out 
various combinations of genes involved in the L-tyrosine biosynthesis to overproduce 
L-tyrosine that has a wide range of industrial applications. In particular, gene 
manipulations were conducted in the wild-type and tyrR knockout strains in order to 
examine whether the tyrR knockout should always be conducted for the enhanced L-
tyrosine production. Starting with individual overexpression of aroGfbr and tyrAfbr, we 
subsequently discovered that co-overexpression of aroGfbr, aroL and tyrC through a 
plasmid pTY13 in the wild-type led to the greatest L-tyrosine production for the 
strains and plasmid constructs examined in this study; tyrC is a gene from Z. mobilis 
functionally similar to tyrAfbr, but insensitive to L-tyrosine. The L-tyrosine production 
performance of the strains overexpressing these three genes was further improved 
upon removal of L-tyrosine-specific and/or general aromatic amino acid transporters 
in the production host, which may serve as important gene manipulation targets for 
further strain optimization for the L-tyrosine production. Among all the strains 
constructed in this study, BTY2.13 overexpressing the abovementioned three genes 
with its L-tyrosine-specific transporter removed consistently showed the greatest L-
tyrosine production performances from both flask cultivation (Figure 5) and fed-batch 
fermentation (Figure 6 and Table 3). The BTY2.13 strain produced up to 43.14 g/L of 
L-tyrosine from its fed-batch fermentation using the exponential-to-DO-stat feeding 
method. This outcome suggested that the tyrR gene knockout was not mandatory for 
the L-tyrosine overproduction, but the production performance of strains having tyrR 
can be highly affected by vector systems (Figure 4) and feeding methods (Table 3) as 
shown in this study. With an optimal vector system and a feeding method, tyrP 
knockout appeared to be more effective in enhancing the L-tyrosine than tyrR 
knockout. 
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Figures 
Figure 1 L-Tyrosine biosynthetic pathway in E. coli. Major genes engineered in this 
study are shown in bold. Metabolite abbreviations are: CHA, chorismate; DAHP, 3-deoxy-
D-arabino-heptulosonate 7-phosphate; DHQ, 3-dehydroquinate; DHS, 3-dehydroshikimate; 
E4P, D-erythrose 4-phosphate; ESPS, 5-enolpyruvoyl-shikimate 3-phosphate; G3P, 
glyceraldehyde 3-phosphate; G6P, glucose 6-phosphate; HPP, 4-hydroxyphenylpyruvate; 
OPP, phenylpyruvate; PEP, phosphoenolpyruvate; PHE, L-phenylalanine; PPA, prephenate; 
PYR, pyruvate; S3P, shikimate 3-phosphate; SHIK, shikimate; TRP, L-tryptophan; TYR, L-
tyrosine. List of the shown genes and their enzyme products are: aroA, 3-phosphoshikimate 
1-carboxyvinyltransferase; aroB, 3-dehydroquinate synthase; aroC, chorismate synthase; 
aroD, 3-dehydroquinate dehydratase; aroE, shikimate dehydrogenase; aroF, aroG, and 
aroH, 3-deoxy-7-phosphoheptulonate synthase; aroK and aroL, shikimate kinase I/II; aroP, 
aromatic amino acid:H+ symporter AroP; pheA, chorismate mutase/prephenate dehydratase; 
tktA, transketolase A; tyrA, chorismate mutase/prephenate dehydrogenase; tyrB, tyrosine 
aminotransferase; tyrP, tyrosine:H+ symporter; ydiB, quinate/shikimate dehydrogenase. The 
dashed line indicates feedback inhibition and the solid line represents TyrR-mediated 
transcriptional regulation. 
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Figure 2 Production performances of the wild-type (BTY0) and the tyrR knockout 
strain (BTY1) individually overexpressing aroGfbr and tyrAfbr using a plasmid 
pTac15K or pTrc99A. Genotypes are shown below each strain name; genes in a 
parenthesis are the ones overexpressed using the indicated plasmid. Value in a 
parenthesis near the bar graph indicates an average OD600 value for the strain. For all 
these flask cultivations, concentrations of both L-phenylalanine and L-tryptophan 
were also measured in addition to L-tyrosine as they could be secreted as byproducts, 
which share biosynthetic pathways with L-tyrosine. However, L-tryptophan was not 
detected in all the flask cultivations. L-Tyrosine was not detected from the BTY0.3 
and BTY0.4 strains. 
 
Figure 3 Production performances of (a) the wild-type (BTY0) and (b) the tyrR 
knockout strain (BTY1) co-overexpressing two genes in various combinations. 
Genotypes are shown below each strain name; genes in a parenthesis are the ones 
overexpressed using the indicated plasmid. Value in a parenthesis near the bar graph 
indicates an average OD600 value for the strain. 
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Figure 4 Production performances of the wild-type (BTY0) and the tyrR knockout 
strain (BTY1) co-overexpressing three genes using (a) a two-vector system and (b) a 
one-vector system. Genotypes are shown below each strain name; genes in a 
parenthesis are the ones overexpressed using the indicated plasmid. Value in a 
parenthesis near the bar graph indicates an average OD600 value for the strain. 
 
Figure 5 Production performances of strains with various genotypes that all 
overexpressed aroGfbr-aroL-tyrC (pBK1). Genotypes are shown below each strain 
name; genes in a parenthesis are the ones overexpressed using the indicated plasmid. 
Value in a parenthesis near the bar graph indicates an average OD600 value for the 
strain. 
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Figure 6 Fed-batch fermentation profile of the strain BTY2.13 showing the best L-
tyrosine production performance. The BTY2.13 strain is a ∆tyrP knockout mutant 
overexpressing aroGfbr-aroL-tyrC (pBK1). Fed-batch fermentation was conducted using the 
exponential-to-DO-stat feeding method (Table 2; and Materials and methods). The vertical 
line in the graph indicates the IPTG induction. Symbols: square, cell growth (OD600); and 
circles, L-tyrosine concentration (g/L). 
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Tables 
Table 1. 
List of plasmids and strains used in this study. Kmr, kanamycin resistance; Ampr, 
ampicillin resistant. 
 Relevant genotype Reference 
Plasmids   
pTac15K tac promoter, p15A origin, Kmr Lab stock 
pTrc99A trc promoter, pBR322 origin, Ampr Lab stock  
pET-22b(+) T7 promoter, pBR322 origin, Ampr Merck Millipore 
pBK1 pTac15K::UNS1-UNS2-UNSx This study 
pBK2 pTac15K::UNS2-UNS3-UNSx This study 
pTY1 pTac15K::aroGfbr (D146N) This study 
pTY2 pTrc99A::aroGfbr (D146N) This study 
pTY3 pTac15K::tyrAfbr (M53I, A354V) This study 
pTY4 pTrc99A::tyrAfbr (M53I, A354V) This study 
pTY5 pTac15K::aroGfbr-aroL This study 
pTY6 pTac15K::aroGfbr-aroK This study 
pTY7 pTac15K::aroGfbr-aroBopt This study 
pTY8 pTac15K::aroGfbr-aroE This study 
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pTY9 pTrc99A::tyrC This study 
pTY10 pBK1::Ptac, aroGfbr-aroL This study 
pTY11 pBK2::Ptrc, tyrC This study 
pTY12 pBK1::Ptac, aroGfbr-aroL, Ptrc, tyrAfbr This study 
pTY13 pBK1::Ptac, aroGfbr-aroL, Ptrc, tyrC This study 
   
Strains   
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F- proAB 
lacIqZΔM15 Tn10 (Tetr)] 
Agilent Technologies 
BTY0 BL21(DE3), F− ompT hsdSB (rB−mB−) gal dcm (DE3) Invitrogen 
BTY1 BL21(DE3)∆tyrR This study 
BTY2 BL21(DE3)∆tyrP This study 
BTY3 BL21(DE3)∆aroP This study 
BTY4 BL21(DE3)∆aroP∆tyrP This study 
BTY5 BL21(DE3)∆tyrR∆tyrP This study 
BTY6 BL21(DE3)∆tyrR∆aroP This study 
BTY7 BL21(DE3)∆tyrR∆aroP∆tyrP This study 
BTY0.1 BTY0 transformed with pTY1 This study 
BTY1.1 BTY1 transformed with pTY1 This study 
  
This article is protected by copyright. All rights reserved. 
A
cc
ep
te
d 
A
rt
ic
le
 
BTY0.2 BTY0 transformed with pTY2 This study 
BTY1.2 BTY1 transformed with pTY2 This study 
BTY0.3 BTY0 transformed with pTY3 This study 
BTY1.3 BTY1 transformed with pTY3 This study 
BTY0.4 BTY0 transformed with pTY4 This study 
BTY1.4 BTY1 transformed with pTY4 This study 
BTY0.5 BTY0 transformed with pTY1 and pTY4 This study 
BTY1.5 BTY1 transformed with pTY1 and pTY4 This study 
BTY0.6 BTY0 transformed with pTY5 This study 
BTY1.6 BTY1 transformed with pTY5 This study 
BTY0.7 BTY0 transformed with pTY6 This study 
BTY1.7 BTY1 transformed with pTY6 This study 
BTY0.8 BTY0 transformed with pTY7 This study 
BTY1.8 BTY1 transformed with pTY7 This study 
BTY0.9 BTY0 transformed with pTY8 This study 
BTY1.9 BTY1 transformed with pTY8 This study 
BTY0.10 BTY0 transformed with pTY4 and pTY5 This study 
BTY1.10 BTY1 transformed with pTY4 and pTY5 This study 
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BTY0.11 BTY0 transformed with pTY5 and pTY9 This study 
BTY1.11 BTY1 transformed with pTY5 and pTY9 This study 
BTY0.12 BTY0 transformed with pTY12 This study 
BTY1.12 BTY1 transformed with pTY12 This study 
BTY0.13 BTY0 transformed with pTY13 This study 
BTY1.13 BTY1 transformed with pTY13 This study 
BTY2.13 BTY2 transformed with pTY13 This study 
BTY3.13 BTY3 transformed with pTY13 This study 
BTY4.13 BTY4 transformed with pTY13 This study 
BTY5.13 BTY5 transformed with pTY13 This study 
BTY6.13 BTY6 transformed with pTY13 This study 
BTY7.13 BTY7 transformed with pTY13 This study 
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Table 2. 
Description of the media in this study. All media components are listed as per liter. 
 
 
Media used for the two different feeding 
methods in fed-batch fermentations 
Shake flask  
Exponential-to-DO-
stat feeding method 
DO-stat feeding 
method 
B
at
ch
 m
ed
ia
 
KH2PO4 6.67 g 3.0 g 4.5 g 
K2HPO4 ---- 7.33 g 11 g 
(NH4)2HPO4 4 g ---- ---- 
Citric acid 0.8 g 0.85 g 1.28 g 
(NH4)2SO4 15 g 15 g 15 g 
Trace metal solution 5 mL 5 mL 8 mL 
Glucose, anhydrous 20 g 20 g 30 g 
MgSO47H2O 0.8 g 0.8 g 1.2 g 
Yeast extract 3.0 g 5.0 g 7.5 g 
Antifoam 204 ---- 4 drops 6 drops 
  
Fe
ed
 m
ed
ia
 
Glucose, anhydrous ---- 700 g 800 g 
MgSO47H2O  ---- 9.0 g 9.0 g 
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(NH4)2SO4 ---- 73 g 73 g 
Yeast extract ---- 5 g 7.5 g 
Trace metal solution ---- 15 mL 15 mL 
35 wt% HCl ---- 1 mL 1 mL 
  
Pr
oc
es
s 
 
pa
ra
m
et
er
s 
pH Setpoint ---- 6.95 
Temperature setpoint 37C 
Nominal gas flowrate ---- 2 L/min 
Initial fill volume ---- 1.6 L 1.6 L 
Media name MR/2 (v1.0) MR/2(v2.0) MR/1.333 
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Table 3. 
Maximum OD600 and L-tyrosine titer of the four strains BTY0.13 (E. coli wild-type), 
BTY2.13 (∆tyrP), BTY5.13 (∆tyrR∆tyrP), and BTY7.13 (∆tyrR∆aroP∆tyrP) from the 
fed-bath fermentations using two different feeding methods. All the four strains have 
aroGfbr-aroL-tyrC (pBK1) overexpressed using a plasmid pTY13, but have different 
genotypes as noted in the parentheses above.  
 
Exponential-to-DO-stat feeding method DO-stat feeding method 
Strain 
Batch 
medium 
Maximu
m 
OD600 
Maxim
um   
L-
tyrosine 
titer 
(g/L) 
Maxim
um   
acetic 
acid 
titer 
(g/L) 
Batch 
medium 
Maxim
um 
OD600 
Maxim
um   
L-
tyrosine 
titer 
(g/L) 
Maxim
um   
acetic 
acid 
titer 
(g/L) 
BTY0.
13 
MR/2 
(v2.0) 
111.25 8.35 0.88 
MR/1.333 
117.19 11.55 5.47 
BTY2.
13 
82.40 43.14 0.92 122.81 8.57 3.88 
BTY5.
13 
113.75 29.32 3.44 110.00 26.96 1.82 
BTY7.
13 
107.19 25.58 1.46 113.44 28.73 0.42 
 
 
